Ypsomed Holding AG
OTC: YPHDF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Simon Michel
- Employees
- 2,644
- Headquarters
- Burgdorf, Switzerland
- IPO year
- 2022
- Market cap
- $5.7B
- Website
- https://www.ypsomed.com
Loading YPHDF…
Loading profile data…Frequently asked questions about YPHDF
What does Ypsomed Holding AG (YPHDF) do?
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such...
Where does YPHDF trade?
Ypsomed Holding AG (YPHDF) trades on the Other OTC.
What sector is YPHDF in?
Ypsomed Holding AG (YPHDF) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Ypsomed Holding AG?
Simon Michel is the chief executive officer of Ypsomed Holding AG (YPHDF).
Where is Ypsomed Holding AG headquartered?
Ypsomed Holding AG is headquartered in Switzerland.
Does YPHDF pay a dividend?
Yes — Ypsomed Holding AG (YPHDF) paid a trailing twelve-month dividend of USD 1.39 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did YPHDF go public?
Ypsomed Holding AG (YPHDF) completed its initial public offering in 2022.